サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1478646

トランスフェクション技術市場、シェア、規模、動向、産業分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024-2032年

Transfection Technologies Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Kits and Reagents); By Application; By End Use; By Region; Segment Forecast, 2024- 2032

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
トランスフェクション技術市場、シェア、規模、動向、産業分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024-2032年
出版日: 2024年04月24日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、トランスフェクション技術の世界市場規模は2032年までに23億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

トランスフェクション技術市場は、機能的ゲノミクスにおける研究の増加によって成長を目の当たりにしています。機能ゲノミクスは、生物のゲノム内の遺伝子機能と相互作用の理解に焦点を当てています。トランスフェクション技術は、核酸を細胞内に導入して遺伝子発現を操作し、生物学的プロセスを研究することで、この研究を促進します。研究者が遺伝子制御や細胞経路を探求するにつれて、高度なトランスフェクション法の需要が高まっています。さらに、CRISPR-Cas9のようなゲノム編集ツールの出現は、効率的なトランスフェクション技術の必要性を高めています。機能ゲノミクス研究と治療開発における継続的な進歩に伴い、トランスフェクション技術市場は、バイオテクノロジーと製薬分野の発展する需要に対応するために拡大しています。

再生医療は組織や臓器の機能を回復させることを目的としており、慢性疾患や傷害に対する有望な治療法を提供します。トランスフェクション技術は、組織再生や免疫調節のためにDNAやRNAなどの治療用核酸を標的細胞に送達する、この分野で極めて重要な技術です。再生医療における研究開発の活発化により、治療用ペイロードの正確な送達を保証する高度なトランスフェクション技術に対する需要が高まっています。

トランスフェクション技術市場は、RNAベースの治療薬の急増によっても成長しています。mRNAワクチンやRNAi治療を含むこれらの治療法は、がんや遺伝性疾患などの疾患に対して有望視されています。トランスフェクション技術は、RNA分子を細胞内に導入して発現させ、治療効果を得るための極めて重要な技術です。遺伝子発現の調節や免疫反応の刺激に不可欠な、正確で効率的な送達を保証するものです。

従来の2次元細胞培養では、生体内環境の複雑さに欠けるため、薬剤開発や疾患モデリングに限界があります。対照的に、3Dモデルは生理学的条件を忠実に再現し、より正確な結果を提供します。トランスフェクション技術は、3D培養に核酸を導入し、遺伝子発現研究やシグナル伝達経路解析を可能にすることで、重要な役割を果たしています。このようなモデルは、薬剤スクリーニングや個別化医療でますます使用されるようになっており、効率的なトランスフェクション法の需要を押し上げています。生物医学研究者や製薬企業が3D細胞培養モデルを採用するにつれて、トランスフェクション技術市場は革新的な研究開発を支援するために大きく成長しています。

トランスフェクション技術市場レポートハイライト

2023年、キット・試薬分野は、幅広い応用範囲、利便性と使いやすさ、一貫性と再現性により、大きな売上シェアを占めました。

2023年には、遺伝子治療の需要増加、ドラッグデリバリーの進歩、RNA治療薬の出現により、治療デリバリー分野が大きな売上シェアを占めました。

2023年には、創薬と開発、生物製剤の生産、規制遵守と品質基準からの需要拡大により、製薬およびバイオテクノロジー企業が大きな収益シェアを占めました。

2023年、北米地域は、強力なバイオテクノロジーと製薬産業、高度なヘルスケアインフラ、高い研究開発費により、大きな市場シェアを占めました。

Bio-Rad Laboratories, Inc.、GenScript Biotech Corporation、Lonza Group Ltd.、Merck KGaA、Mirus Bio LLC、Promega Corporation、QIAGEN N.V.、Thermo Fisher Scientific Inc.など、世界的に存在感を示す市場プレーヤーが存在するため、市場競争は激しいです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のトランスフェクション技術市場の洞察

  • 最終用途スナップショット
  • トランスフェクション技術市場力学
    • 促進要因と機会
      • 遺伝子治療と細胞ベースの治療の増加により、製品の需要が促進されると予測されています。
      • バイオ医薬品調査の拡大により、トランスフェクション技術市場の成長が促進されると予想されます。
    • 抑制要因と課題
      • トランスフェクション効率と変動性
  • PESTEL分析
  • トランスフェクション技術市場の最終用途の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のトランスフェクション技術市場：用途別

  • 主な調査結果
  • イントロダクション
  • タンパク質生産
  • 生物医学調査
  • 治療の実施
  • その他

第6章 世界のトランスフェクション技術市場：製品別

  • 主な調査結果
  • イントロダクション
  • 装置
  • キットと試薬

第7章 世界のトランスフェクション技術市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • CROとCDMO
  • 製薬・バイオテクノロジー企業
  • 研究機関
  • その他

第8章 世界のトランスフェクション技術市場：地域

  • 主な調査結果
  • イントロダクション
    • トランスフェクション技術市場評価：地域、2019-2032年
  • 北米
    • 北米：用途別、2019-2032年
    • 北米：最終用途別、2019年～2032年
    • 北米：製品別、2019-2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：用途別、2019-2032年
    • 欧州：最終用途別、2019-2032年
    • 欧州：製品別、2019-2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域：用途別、2019-2032年
    • アジア太平洋地域：最終用途別、2019年～2032年
    • アジア太平洋地域：製品別、2019年～2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ：用途別、2019-2032年
    • 中東・アフリカ：最終用途別、2019-2032年
    • 中東・アフリカ：製品別、2019年～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：用途別、2019-2032年
    • ラテンアメリカ：最終用途別、2019-2032年
    • ラテンアメリカ：製品別、2019-2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Altogen Biosystems
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Lonza Group Ltd
  • MaxCyte, Inc.
  • Merck KGaA
  • Mirus Bio LLC
  • OriGene Technologies, Inc.
  • Polyplus-transfection SA
  • Promega Corporation
  • QIAGEN N.V.
  • SignaGen Laboratories
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc.
  • Viromer
図表

List of Tables

  • Table 1 Global Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Global Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 4 Transfection Technologies Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 6 North America: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 9 U.S.: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 12 Canada: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 15 Europe: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 UK: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 18 UK: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 20 France: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 21 France: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 27 Italy: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 30 Spain: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Russia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 China: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 42 China: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 44 India: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 45 India: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Japan: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 57 South Korea: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 66 UAE: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 69 Israel: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 72 South Africa: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 75 Latin America: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 78 Mexico: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Brazil: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Argentina: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Transfection Technologies Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Transfection Technologies Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Transfection Technologies Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Transfection Technologies Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 12. Transfection Technologies Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Transfection Technologies Market
目次
Product Code: PM4847

The global Transfection Technologies market size is expected to reach USD 2.33 billion by 2032, according to a new study by Polaris Market Research. The report "Transfection Technologies Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Kits and Reagents); By Application; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The transfection technologies market is witnessing growth driven by increased research in functional genomics. Functional genomics focuses on understanding gene function and interactions within an organism's genome. Transfection technologies facilitate this research by delivering nucleic acids into cells to manipulate gene expression and study biological processes. As researchers explore gene regulation and cellular pathways, the demand for advanced transfection methods rises. Additionally, the emergence of genome editing tools like CRISPR-Cas9 amplifies the need for efficient transfection techniques. With ongoing advancements in functional genomics research and therapeutic development, the transfection technologies market is expanding to meet the evolving demands of the biotechnology and pharmaceutical sectors.

Regenerative medicine aims to restore tissue and organ function, offering promising treatments for chronic diseases and injuries. Transfection technologies are crucial in this field, delivering therapeutic nucleic acids like DNA and RNA into target cells for tissue regeneration and immune modulation. The increased research and development in regenerative medicine results in greater demand for advanced transfection technologies ensuring precise delivery of therapeutic payloads.

The transfection technologies market is also growing due to the surge in RNA-based therapeutics. These therapies, including mRNA vaccines and RNAi treatments, hold promise for diseases like cancer and genetic disorders. Transfection technologies are pivotal, delivering RNA molecules into cells for expression and therapeutic effects. They ensure precise and efficient delivery, vital for modulating gene expression and stimulating immune responses.

Traditional 2D cell cultures lack the complexity of in vivo environments, limiting drug development and disease modeling. In contrast, 3D models closely replicate physiological conditions, offering more accurate results. Transfection technologies play a crucial role by delivering nucleic acids into 3D cultures, enabling gene expression studies and signaling pathway analysis. These models are increasingly used in drug screening and personalized medicine, boosting demand for efficient transfection methods. As biomedical researchers and pharmaceutical companies embrace 3D cell culture models, the transfection technologies market sees substantial growth to support innovative research and development efforts.

Transfection Technologies Market Report Highlights

In 2023, the kits and reagents segment held significant revenue share owing to wide range of applications, convenience & ease of use, and consistency & reproducibility.

In 2023, the therapeutic delivery segment held significant revenue share owing to rising demand for gene therapy, advancements in drug delivery, and emergence of RNA therapeutics.

In 2023, the pharmaceutical and biotech companies segment held significant revenue share owing to greater demand from drug discovery and development, biologics production, and regulatory compliance and quality standards.

In 2023, North America region accounted for a significant market share due to strong biotechnology and pharmaceutical industry, advanced healthcare infrastructure, and high research and development spending.

The market is highly competitive owing to the existence of market players with a global presence, including Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. among others.

Polaris Market Research has segmented the Transfection Technologies market report based on product, application, end use, and region:

Transfection Technologies, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Equipment
  • Kits and Reagents

Transfection Technologies, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Protein Production
  • Biomedical Research
  • Therapeutic Delivery
  • Others

Transfection Technologies, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • CROs and CDMOs
  • Pharmaceutical and Biotech Companies
  • Research Institutes
  • Others

Transfection Technologies, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Transfection Technologies Market Insights

  • 4.1. Transfection Technologies Market - End Use Snapshot
  • 4.2. Transfection Technologies Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in gene therapy and cell-based therapies is projected to spur the product demand
      • 4.2.1.2. Expansion of biopharmaceutical research is expected to drive transfection technologies market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Transfection efficiency and variability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Transfection Technologies Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Transfection Technologies Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • 5.3. Protein Production
    • 5.3.1. Global Transfection Technologies Market, by Protein Production, by Region, 2019-2032 (USD Billion)
  • 5.4. Biomedical Research
    • 5.4.1. Global Transfection Technologies Market, by Biomedical Research, by Region, 2019-2032 (USD Billion)
  • 5.5. Therapeutic Delivery
    • 5.5.1. Global Transfection Technologies Market, by Therapeutic Delivery, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Transfection Technologies Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Transfection Technologies Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Equipment
    • 6.3.1. Global Transfection Technologies Market, by Equipment, by Region, 2019-2032 (USD Billion)
  • 6.4. Kits and Reagents
    • 6.4.1. Global Transfection Technologies Market, by Kits and Reagents, by Region, 2019-2032 (USD Billion)

7. Global Transfection Technologies Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • 7.3. CROs and CDMOs
    • 7.3.1. Global Transfection Technologies Market, by CROs and CDMOs, By Region, 2019-2032 (USD Billion)
  • 7.4. Pharmaceutical and Biotech Companies
    • 7.4.1. Global Transfection Technologies Market, by Pharmaceutical and Biotech Companies, By Region, 2019-2032 (USD Billion)
  • 7.5. Research Institutes
    • 7.5.1. Global Transfection Technologies Market, by Research Institutes, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Transfection Technologies Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Transfection Technologies Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Transfection Technologies Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Transfection Technologies Market - North America
    • 8.3.1. North America: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.3.2. North America: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Transfection Technologies Market - U.S.
      • 8.3.4.1. U.S.: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Transfection Technologies Market - Canada
      • 8.3.5.1. Canada: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Transfection Technologies Market - Europe
    • 8.4.1. Europe: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Transfection Technologies Market - UK
      • 8.4.4.1. UK: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Transfection Technologies Market - France
      • 8.4.5.1. France: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Transfection Technologies Market - Germany
      • 8.4.6.1. Germany: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Transfection Technologies Market - Italy
      • 8.4.7.1. Italy: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Transfection Technologies Market - Spain
      • 8.4.8.1. Spain: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Transfection Technologies Market - Netherlands
      • 8.4.9.1. Netherlands: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Transfection Technologies Market - Russia
      • 8.4.10.1. Russia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Transfection Technologies Market - Asia Pacific
    • 8.5.1. Asia Pacific: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Transfection Technologies Market - China
      • 8.5.4.1. China: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Transfection Technologies Market - India
      • 8.5.5.1. India: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Transfection Technologies Market - Malaysia
      • 8.5.6.1. Malaysia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Transfection Technologies Market - Japan
      • 8.5.7.1. Japan: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Transfection Technologies Market - Indonesia
      • 8.5.8.1. Indonesia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Transfection Technologies Market - South Korea
      • 8.5.9.1. South Korea: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Transfection Technologies Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Transfection Technologies Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Transfection Technologies Market - UAE
      • 8.6.5.1. UAE: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Transfection Technologies Market - Israel
      • 8.6.6.1. Israel: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Transfection Technologies Market - South Africa
      • 8.6.7.1. South Africa: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Transfection Technologies Market - Latin America
    • 8.7.1. Latin America: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Transfection Technologies Market - Mexico
      • 8.7.4.1. Mexico: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Transfection Technologies Market - Brazil
      • 8.7.5.1. Brazil: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Transfection Technologies Market - Argentina
      • 8.7.6.1. Argentina: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Altogen Biosystems
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bio-Rad Laboratories, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. GenScript Biotech Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Lonza Group Ltd
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. MaxCyte, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck KGaA
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mirus Bio LLC
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. OriGene Technologies, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Polyplus-transfection SA
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Promega Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. QIAGEN N.V.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. SignaGen Laboratories
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Takara Bio Inc
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Thermo Fisher Scientific Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Viromer
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development